Clinical Trials
3 trialsNCT06199882 2024-10-15
SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma
Zhejiang Cancer Hospital
Phase 2 Suspended
NCT04984980 2023-01-26
Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer
Fudan University
Phase 2 Unknown
NCT04979663 2021-08-09
GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer
Fudan University
Phase 1/2 Unknown